Journal of Nutrition and Health

The Korean Nutrition Society (한국영양학회)
권호 표지

Changes in Plasma Lipid Pattern in Streptozotocin-Induced Diabetic Rats: A Time Course Study

스트렙토토신-당뇨쥐의 유병기간에 따른 혈중지질패턴의 경시적 변화

  • 이수자 (경북대학교 식품영양학과)
  • Published : 1999.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

This study was carrid out to examine a part of the mechanism for the etiology of diabetic complications. Thirty normal and forty streptozotocin(STZ)-induced diabetic rats were used as the animal models. Animals were sacrificed at the time points of 3 days, 1, 2, 4 and 6 weeks after STZ-injection and time course in body weight and organ weight, the levels of blood glucose, plasma lipid patterns, and atherogenic index were measured during 6 weeks. The STZ-diabetic animals showed 63% survival rate and fsting blood glucose levels of the diabetic animals measured in the range of 230-410mg/dL during the experimental period. The body weigh of diabetic animals decreased significantly throughout the experimental period and the relative weights of organs to body weight were significantly higher than the normal control ones. The enlargement of the kidney in the diabetic animals was especially remarkable. Plasma triglyceride concentration in diabetic rats substancially increased from the first week of onset of diabetes mellitus and maintained higher levels than the control ones throughout the whole experimental period. The plasma total cholesterol level and atherogenic index in the diabetic rats were significantly higher than the normal ones from the third day after STZ injection and showed a gradual increase with the duration of the disease. Throughout the experiment, the diabetic rats consistently showed a slightly lower HDL-cholesterol level compared to the normal animals. From the results of this study, it appears that the significant changes in blood lipid pattern in STZ-diabetic animals start from the first week after STZ injection.

Keywords

References

  1. Top Clin Nutr v.3 Source and amount of dietary carbohydrate in patients with noninsulin-dependent diabetes mellitus Coulston AM;Hollenbeck CB
  2. Diabetologia v.26 Non-enzymatic glycosylation and the chronic complications of diabetes Kennedy L;Baynes JW
  3. Diabetes Care v.4 Lipid disorders in diabetes Goldberg RB
  4. Am J Med v.83 Abnormal lipoprotein matabolism in non-insulin dependent diabetes mellitus Reaven KM
  5. Diabetes Care v.6 The role of circulation glucose and triglyceride concentrations and their interaction with other risk factors and determinations of arterial disease in nine diabetic population samples from the WHO multinational study West KM;Ahuja MM;Bennet PH
  6. Joslin's Diabetes Mellitus(12th edition) Pathogenesis of macrovascular disease including the influence of lipids Ganda OP
  7. Arteriosclerosis v.6 no.6 Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus Laako M;Pyorala K;Sarlund H;Voutilainen E
  8. Diabetes v.31 Nonenzymatic glycosylation of low-density lipoprotein alters its biologic activity Witztum JL;Mahoney EM;Branks MJ;Fisher M;Elam R;Steinberg D
  9. Diabetes v.37 Glycosylation of low-density lipoprotein enhances cholesterl ester synthesis in human monocyte-derived macrophages Lopes-Virella MF;Klein RL;Lyons TJ;Stevenson HC;Witztum JL
  10. Diabetes v.39(suppl. 1) Enhancement of platelet aggregation by the glycosylated subfraction of low-density lipoprotein isolated from patients with insulin-dependent diabetes mellitus Klein RL;Lopes-Virella MF;Colwell JA
  11. Biochem J v.245 Glucose autoxidation and protein modification: The potential role "autoxidative glycosylation" in diabetes mellitus Wolff SP;Dean RT
  12. Clin Chem v.19 Quantitative determination of serum triglycerides by use of enzymes Bucolo G;David H
  13. Clin Chem v.20 Enzymatic determination of total serum cholesterol Allain CC;Poon LS;Chen CSG;Richmond W
  14. Clin Chem v.24 Cholesterol in high-density lipoprotein: Use of Mg²+ / dextran sulfate in its measurement Finley PR;Schifman RB;William J;Lichti DA
  15. Mulivariate date analysis with readings(4th edition) Hair JF;Anderson RE;Tatham RL;Black WC
  16. Horm Metab Res v.26 Serum antioxidant status in streptozotocin-induced diabetic rat Asayama K;Nakane T;Uchida N;Hayashibe H;Dobashi K
  17. Immunol & Cell Biol v.72 Lipid peroxidation, glutathione levels and changes in glutathione-related enzyme activities in streptozotocin-induced diabetes rats Mukherjee B;Mukherjee JR;Chatterjee M
  18. J Lipid Res v.30 Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity Morel DW;Chisolm GM
  19. Life-Sci v.55 no.1 Protective effects of metallothionein on streptozotocin-induced diabetes in rats Yang J;Cherian MG
  20. Indian J Exp Biol v.34 no.2 Antioxidant status of streptozotocin diabetic rats Garg MC;Ojha S;Bansal DD
  21. Free radical Biol Med v.18 no.2 Elevated lipid peroxidation and vitamin E-quinone levels in heart ventricles of streptozotocin-treated diabetic rats Jain SK;Levine SN
  22. Nutr Res v.18 no.1 Antidiabetic influence of dietary cumin seeds in streptozotocin-induced diabetic rats Willatgamuwa SA;Platel K;Saraswathi G;Srinivasan K
  23. Mol Cell Biochem v.151 no.2 Lipid peroxidation and activity of antioxidant enzymes in diabetic rats Kakkar R;Kalra J;Mantha SV;Prasad K
  24. Korean J Nutr v.27 no.4 The effect of dietary fiber feeding on gastrointestinal functions and lipid metabolism in streptozotocin-induced diabetic rats Park SH;Lee YK;Lee HS
  25. Korean J Nutr v.29 no.3 A study on the development of high-fier supplements for the diabetic patients(I) Effect of seaweed supplementation on the gastrointestinal function and diabetic symptom control in streptozotocin-induced diabetic rats Lee HS;Choi MS;Lee YK;Park SH;Kim YJ
  26. Nutr Res v.11 Diabetic parameters 58 weeks after injection with streptozotocin in rats fed basal diets or diets supplemented with fiber, minerals and vitamins Preston Am;Tome J;Morales JJ;Milan L;Cuevas AA;Medina J;Santiago JA
  27. J Japn Soc Nutr and Food Sci v.45 no.1 Ameliorating effects of an intestinal disaccharidase inhibitor, AO-128, in streptozotocin-diabetic rats Odaka H;Matsuo T
  28. J Nutr v.123 Dietary sorbose prevents and improves hyperglycemia in genetically diabetc mice Furuse M;Kimura C;Mabayo RT;Takahashi H;Okumura J
  29. Lipids v.28 Diabetes increase excretion of urinary malondialdehyde conjugates in rats Gallaher DD;Csallany AS;Shoeman DW;Olson JM
  30. Diabetes v.14 no.1 Early renal hypertrophy and kidney tissue IGF-I in streptozotocin-induced diabetic rats Hong SK;Koh KS;Kim SY;Cho BY;Lee HK;Koh CS;Min HK;Lee BD;Jang HC
  31. Scan J Clin Invest v.28 Glomerular filtration rate and renal plasma flow in short term and long tern juvenile diabetes Mogensen CE
  32. Diabetologia v.13 Renal hypertrophy in experimental diabetes: Relation to severity of diabetes Seyer-Honsen K
  33. Ann Rev Med v.36 The molecular mechanism of insulin action Kahn CR
  34. Diabetes Care v.4 Lipid disorders in diabetes Goldberg RB
  35. Diabetes mellitus and hyperlipidemia Choi YG;Lee TH
  36. Indian J Biochem Biophys v.22 Effects of wheat bran fibre on tissue lipids in diabetic rats Goswamy S;Many I;Many UV
  37. N Eng J Med v.298 Hypertriglyceridemia associated with deficiency of apolipoprotein C-II Steiner G;Chow A;Little JA
  38. Diabetes v.33 In vivo stimulation of low-density lipoprotein degradation by insulin Chait A;Foster D;Mazzone T
  39. Diabetes v.30(supple.2) Cholesterol metabolism in diabtes mellitus Saudek CD;Yong NL
  40. Ann Intern Med v.101 Nonenzymatic glycosylation and the pathogenesis of diabetic complication Brownlee M;Vlassara H;Cerami A
  41. Annu Rev Biochem v.46 The low-density lipoprotein pathway and its relation to atherosclerosis Goldstein JL;Brown MS
  42. Bri J Nutr v.72 The effects of dietary sugarbeet fibre and guar gum on lipid metabolism in Wistar rats Overton PD;Furlonger N;Beety JM;Chakraborty J;Tredger JA;Morgan LM
  43. Clinician v.8 no.1 Diabetic dyslipidemia:Results from the Prospective Cardiovascular Muenster(PROCAM) Study Assmann G